NVS
$132.42
Revenue | $14358Mn |
Net Profits | $3928Mn |
Net Profit Margins | 27.36% |
Novartis Ag’s revenue jumped 9% since last year same period to $14358Mn in the Q3 2025. On a quarterly growth basis, Novartis Ag has generated -3.22% fall in its revenue since last 3-months.
Novartis Ag’s net profit jumped 23.17% since last year same period to $3928Mn in the Q3 2025. On a quarterly growth basis, Novartis Ag has generated -2.8% fall in its net profits since last 3-months.
Novartis Ag’s net profit margin jumped 13% since last year same period to 27.36% in the Q3 2025. On a quarterly growth basis, Novartis Ag has generated 0.44% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.31 |
EPS Estimate Current Year | 2.31 |
Novartis Ag’s earning per share (EPS) estimates for the current quarter stand at 2.31 - a -2.53% fall from last quarter’s estimates.
Novartis Ag’s earning per share (EPS) estimates for the current year stand at 2.31.
Earning Per Share (EPS) | 2.42 |
Novartis Ag’s earning per share (EPS) jumped 22.84% since last year same period to 2.42 in the Q2 2025. This indicates that the Novartis Ag has generated 22.84% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-03-31 | 2.17 | 2.28 | 5.07% |
2025-07-17 | 2.37 | 2.42 | 2.11% |